Collateral for a security interest recorded Apr 8, 2026 (Royal Bank of Canada).
Term ended no later than Nov 4, 2026 · Low confidence
20-year base term ended Feb 2, 2026
Held by Gynesonics, Inc.
Filed Dec 20, 2010 as application 12/973,642 · Granted Nov 7, 2017
Base term plus 275 days of patent term adjustment (USPTO delay)
Today
Ended no later than Nov 4, 2026
2006
2026
Clock starts
Feb 2, 2006
Feb 2, 2006
Ended no later than
Nov 4, 2026
Nov 4, 2026
Granted
Nov 7, 2017
Nov 7, 2017
base term
patent term adjustment
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
275
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
7
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 275 days past its 20-year base term on prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Feb 2, 2006, when application 11/347,018, the earliest non-provisional in its chain, was filed (this one was filed Dec 20, 2010); a parent in its chain could not be resolved (the next row) | Feb 2, 2026 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | +275 days, USPTO patent term adjustment record | Nov 4, 2026 | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | no later than Nov 4, 2026 | Low confidence |
This family
| US 7,918,795 | In force Mar 2028 | Mar 2028 |
| US 9,808,310 | this patent no later than Nov 2026 | no later than Nov 2026 |
| US 9,987,080 | Term ended Feb 2026 | Feb 2026 |
| US 10,182,862 | Term ended Feb 2026 | Feb 2026 |
| US 11,419,668 | Term ended Sep 2026 | Sep 2026 |
| US 11,950,837 | Term ended Feb 2026 | Feb 2026 |
| US 12,414,813 | Term ended Feb 2026 | Feb 2026 |
The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jul 26, 2017 Reel 43100, frame 783 | Grossman, Jessica | Gynesonics, Inc. | Assignment of Assignor's Interest |
| Feb 14, 2025 Reel 70236, frame 154 | Gynesonics, Inc. | Bank of America, N.A., as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75462, frame 440 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Royal Bank of Canada, as Collateral Agent | Security Interest |
| Apr 8, 2026 Reel 75926, frame 339 | Biotheranostics, Inc.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Cytyc Corporation; Suros Surgical Systems, Inc.; Gynesonics, Inc.; Bolder Surgical, LLC; Faxitron Bioptics, LLC; Health Beacons, Inc.; Hologic, Inc. | Citibank, N.A., as Collateral Agent | Security Interest |
| Apr 24, 2026 Reel 75455, frame 789 | Bank of America, N.A., as Collateral Agent | Gynesonics, Inc. | Release of Security Interest Recorded at Reel/Frame 070236/0154 |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
A terminal disclaimer is on file and its reference is not resolved. No cap is applied and none is guessed
Note
The 275 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Open question
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Nov 4, 2026. We will not guess the cap.
Citations
27
later US patents cite this one
That is top 25% of utility patents granted in 2017 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
This computed term ends no later than the date shown; an unresolved terminal disclaimer may end it earlier. Related patents and pending applications may cover overlapping subject matter.